title: Adherence to treatment is a complex and multifaceted issue that can substantially alter the outcome of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Fabio
authors.initials: F
authors.lastname: Efficace
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
mesh_terms: D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D016903:Drug Monitoring
chemical_list: D047428:Protein Kinase Inhibitors